Publications by authors named "Peter M Ravdin"

38Publications

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.

N Engl J Med 2019 06 3;380(25):2395-2405. Epub 2019 Jun 3.

From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana-Farber Cancer Institute, Boston (R.J.G.); University of Texas, San Antonio (P.M.R.); Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada; Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.); University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O., J.A.) - both in North Carolina; Mayo Clinic, Jacksonville, FL (M.P.G.); National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L.); Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis; Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin; Washington University, St. Louis (M.J.E.); the National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and the University of Pittsburgh (A.M.B.), Pittsburgh; Emory University, Atlanta (W.C.W.); Cancer Trials Ireland, Dublin (M.M.K.); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.); Cancer Center of Kansas, Wichita (P.S.R.); Vanderbilt University, Nashville (I.A.M.); Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.); and the University of Hawaii Cancer Center, Honolulu (J.L.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1904819DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709671PMC
June 2019

Communicating Risks of Adjuvant Chemotherapy for Breast Cancer: Getting Beyond the Laundry List.

J Oncol Pract 2019 02 14;15(2):e98-e109. Epub 2018 Dec 14.

5 UCLA School of Medicine, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374637PMC
February 2019

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

N Engl J Med 2018 Jul 3;379(2):111-121. Epub 2018 Jun 3.

From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana-Farber Cancer Institute, Boston (R.J.G.); Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada; Loyola University Chicago Stritch School of Medicine, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.); University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O.) - both in North Carolina; Mayo Clinic, Jacksonville, FL (M.P.G.); National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L., J.A.); Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis; Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin; Washington University, St. Louis (M.J.E.); National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and University of Pittsburgh (A.M.B.), Pittsburgh; Emory University, Atlanta (W.C.W.); University of Texas, San Antonio (P.M.R.); Cancer Trials Ireland, Dublin (M.M.K.); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.); Cancer Center of Kansas, Wichita (P.S.R.); Vanderbilt University, Nashville (I.A.M.); Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.); and University of Hawaii Cancer Center, Honolulu (J.L.B.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1804710
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1804710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172658PMC
July 2018

Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.

Eur J Cancer 2017 06 14;78:37-44. Epub 2017 Apr 14.

Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.03.015DOI Listing
June 2017

Epidemiology of GIST in the Era of Histology Codes--Letter.

Cancer Epidemiol Biomarkers Prev 2015 Jun;24(6):998

The University of Texas Health Sciences Center, San Antonio, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0001DOI Listing
June 2015

Independent prognostic value of screen detection in invasive breast cancer.

J Natl Cancer Inst 2011 Apr 24;103(7):585-97. Epub 2011 Feb 24.

Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr043DOI Listing
April 2011

The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemoprevention.

Authors:
Peter M Ravdin

Cancer Prev Res (Phila) 2010 Jun;3(6):686-8

University of Texas Health Sciences Center at San Antonio, 78229, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-10-0100DOI Listing
June 2010

Ki67 in breast cancer: prognostic and predictive potential.

Lancet Oncol 2010 Feb;11(2):174-83

Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(09)70262-1DOI Listing
February 2010

Hormone replacement therapy and the increase in the incidence of invasive lobular cancer.

Authors:
Peter M Ravdin

Breast Dis 2008-2009;30:3-8

University of Texas Health Sciences Center, San Antonio, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BD-2009-0283DOI Listing
December 2012

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.

Oncologist 2009 Apr 3;14(4):320-68. Epub 2009 Apr 3.

Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY 12208, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2008-0230DOI Listing
April 2009

Sustained lower rates of breast cancer in the United States.

Breast Cancer Res Treat 2009 Sep 1;117(1):223-4. Epub 2008 Nov 1.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-008-0226-8
Publisher Site
http://dx.doi.org/10.1007/s10549-008-0226-8DOI Listing
September 2009

Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.

J Clin Oncol 2008 May 31;26(13):2112-7. Epub 2008 Mar 31.

Department of Radiation Medicine, KPV4, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239-3098, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.7934DOI Listing
May 2008

Breast cancer trends: a marriage between clinical trial evidence and epidemiology.

J Natl Cancer Inst 2007 Aug 24;99(15):1139-41. Epub 2007 Jul 24.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djm080DOI Listing
August 2007

The decrease in breast-cancer incidence in 2003 in the United States.

N Engl J Med 2007 Apr;356(16):1670-4

Department of Biostatistics, M.D. Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMsr070105DOI Listing
April 2007

Prognosis of patients with resected non-small cell lung cancer: impact of clinical and pathologic variables.

Lung Cancer 2006 May 29;52(2):207-12. Epub 2006 Mar 29.

Division of Medical Oncology, University of Texas Health Sciences Center at San Antonio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2006.01.016DOI Listing
May 2006

A decision aid to assist in adjuvant therapy choices for breast cancer.

Psychooncology 2006 Nov;15(11):1001-13

Case Western Reserve University, Cleveland, OH 44106-4976, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.1040DOI Listing
November 2006

Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information.

Med Decis Making 2005 May-Jun;25(3):301-7

Department of Health Policy & Management, Graduate School of Public Health, University of Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://mdm.sagepub.com/content/25/3/301.full.pdf
Web Search
http://mdm.sagepub.com/cgi/doi/10.1177/0272989X05276851
Publisher Site
http://dx.doi.org/10.1177/0272989X05276851DOI Listing
November 2005

Population-based validation of the prognostic model ADJUVANT! for early breast cancer.

J Clin Oncol 2005 Apr;23(12):2716-25

Breast Cancer Outcomes Unit, Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.06.178DOI Listing
April 2005

Managing the risk of osteoporosis in women with a history of early breast cancer.

Authors:
Peter M Ravdin

Oncology (Williston Park) 2004 Oct;18(11):1385-90, 1393; discussion 1394

University of Texas Health Science Center San Antonio, Texas 78259-2307, USA.

View Article

Download full-text PDF

Source
October 2004

A method for making estimates of the benefit of the late use of letrozole in patients completing 5 years of tamoxifen.

Clin Breast Cancer 2004 Oct;5(4):313-6

Division of Oncology, University of Texas Health Sciences Center, San Antonio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/cbc.2004.n.047DOI Listing
October 2004

A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.

Breast Cancer Res Treat 2004 05;85(2):143-50

James P. Wilmot Cancer Center, University of Rochester Medical Center, University of Rochester School of Medicine, Strong Memorial Hospital, Rochester, NY 14642-0001, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/B:BREA.0000025405.63953.f9DOI Listing
May 2004

Decision-making for patients with resectable breast cancer: individualized decisions for and by patients and their physicians.

J Natl Compr Canc Netw 2003 Apr;1(2):189-96

Mayo Clinic, Rochester, Minnesota 550905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2003.0017DOI Listing
April 2003

Choosing between endocrine therapy and chemotherapy--or is there a role for combination therapy?

Breast Cancer Res Treat 2002 Oct;75 Suppl 1:S37-44; discussion S57-9

Department of Surgical Oncology, University of Newcastle, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1020365800921DOI Listing
October 2002